Business Segments and Geographic Areas

12 Months Ended

Dec. 31, 2011

Segment Reporting [Abstract]

Business Segments and Geographic Areas

Business Segments and Geographic Areas

CONMED conducts its business through five principal operating segments, CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.  We believe each of our segments are similar in the nature of products, production processes, customer base, distribution methods and regulatory environment.  Our CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec operating segments also have similar economic characteristics and therefore qualify for aggregation.  Our CONMED Patient Care and CONMED Endoscopic Technologies operating units do not qualify for aggregation since their economic characteristics do not meet the criteria for aggregation as a result of the lower overall operating income (loss) in these segments.

CONMED Endosurgery, CONMED Electrosurgery and CONMED Linvatec consist of a single aggregated segment comprising a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic procedures, electrosurgical generators and related surgical instruments, arthroscopic instrumentation for use in orthopedic surgery and small bone, large bone and specialty powered surgical instruments.  CONMED Patient Care product offerings include a line of vital signs and cardiac monitoring products as well as suction instruments & tubing for use in the operating room.  CONMED Endoscopic Technologies product offerings include a comprehensive line of minimally invasive endoscopic diagnostic and therapeutic instruments used in procedures which require examination of the digestive tract.

The following is net sales information by product line and reportable segment:

	2009		2010		2011
Arthroscopy	$	269,820	$	288,421	$	289,878
Powered Surgical Instruments	144,014		142,288		147,849
CONMED Linvatec	413,834		430,709		437,727
CONMED Electrosurgery	94,959		97,210		98,632
CONMED Endosurgery	66,027		69,004		73,716
CONMED Linvatec, Electrosurgery,
and Endosurgery	574,820		596,923		610,075
CONMED Patient Care	70,978		68,283		65,651
CONMED Endoscopic Technologies	48,941		48,517		49,351
Total	$	694,739	$	713,723	$	725,077

Total assets, capital expenditures, depreciation and amortization information are impracticable to present by reportable segment because the necessary information is not available.

The following is a reconciliation between segment operating income (loss) and income (loss) before income taxes.  The Corporate line includes corporate related items not allocated to operating units:

	2009			2010			2011
CONMED Linvatec, Electrosurgery
and Endosurgery	$	62,715		$	77,271		$	89,093
CONMED Patient Care	(1,263		)	(38		)	(62,878		)
CONMED Endoscopic Technologies	(7,904		)	(1,315		)	273
Corporate	(25,279		)	(18,825		)	(18,214		)
Income from operations	28,269			57,093			8,274
Gain (loss) on early extinguishment of debt	1,083			(79		)	—
Amortization of bond discount	4,111			4,244			3,903
Interest expense	7,086			7,113			6,676
Income (loss) before income taxes	$	18,155		$	45,657		$	(2,305	)

Net sales information for geographic areas consists of the following:

	2009		2010		2011
United States	$	385,770	$	371,914	$	364,588
Canada	48,713		61,593		65,794
United Kingdom	35,155		31,576		32,106
Japan	29,244		32,226		34,178
Australia	30,159		34,564		40,122
All other countries	165,698		181,850		188,289
Total	$	694,739	$	713,723	$	725,077

Sales are attributed to countries based on the location of the customer. There were no significant investments in long-lived assets located outside the United States at December 31, 2010 and 2011.  No single customer represented over 10% of our consolidated net sales for the years ended December 31, 2009, 2010 and 2011.